Precision Biosciences Inc
DTIL- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001357874
In the last 90 days, Precision Biosciences Inc insiders filed 2 open-market purchases and 0 sales; 95 institutions reported holding it in 13F filings for Q2 2026, worth $138.9M in total; no superinvestor holds it.
13F holders, Q2 2021
Institutional positions in Precision Biosciences Inc as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 131
- +4 vs. Q1 2021
- Shares held
- 28.7M
- −1.53M (−5.1%) vs. Q1 2021
- Total value
- $357.6M
- +$44.6M (+14.3%) vs. Q1 2021
- New holders
- 21
- 45 more added
- Sold out
- 17
- 42 more reduced
1 institution that held it in Q1 2021 haven't filed for Q2 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting DTIL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 95 | $138.9M |
| Q1 2026 | 78 | $88.1M |
| Q4 2025 | 69 | $62.8M |
| Q3 2025 | 56 | $25.7M |
| Q2 2025 | 52 | $18.6M |
| Q1 2025 | 48 | $18.1M |
| Q4 2024 | 55 | $14.7M |
| Q3 2024 | 51 | $29.8M |
| Q2 2024 | 47 | $30.8M |
| Q1 2024 | 43 | $42.8M |
| Q4 2023 | 66 | $12.8M |
| Q3 2023 | 77 | $11.8M |
| Q2 2023 | 77 | $23.0M |
| Q1 2023 | 86 | $36.5M |
| Q4 2022 | 102 | $60.1M |
| Q3 2022 | 103 | $67.2M |
| Q2 2022 | 121 | $93.5M |
| Q1 2022 | 153 | $96.6M |
| Q4 2021 | 134 | $233.4M |
| Q3 2021 | 132 | $336.5M |
| Q2 2021 | 131 | $357.6M |
| Q1 2021 | 128 | $313.0M |
Institutions, Q2 2021
Shares, value and share of portfolio for each institution holding Precision Biosciences Inc; share changes are against Q1 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Nachman Norwood & Parrott, Inc | 148,456 | $1.86M | 0.19% | −7,114−4.6% | Reduced |
| Bank of New York Mellon Corp | 149,247 | $1.87M | 0.00% | −24,708−14.2% | Reduced |
| Two Sigma Investments, LP | 151,604 | $1.90M | 0.01% | +151,604 | New |
| Panagora Asset Management Inc | 158,936 | $1.99M | 0.01% | +139,726+727.4% | Added |
| Nuveen Asset Management, LLC | 164,504 | $2.06M | 0.00% | −10,661−6.1% | Reduced |
| Voloridge Investment Management, LLC | 165,598 | $2.07M | 0.01% | −72,770−30.5% | Reduced |
| HRT Financial LP | 171,071 | $2.14M | 0.02% | +171,071 | New |
| Integral Health Asset Management, LLC | 175,000 | $2.19M | 0.60% | +175,000 | New |
| Adams Chetwood Wealth Management LLC | 180,179 | $2.26M | 1.59% | 00.0% | Unchanged |
| Jacob Asset Management of New York LLC | 211,000 | $2.64M | 0.87% | +72,000+51.8% | Added |
| Citigroup Inc | 234,872 | $2.94M | 0.00% | −156,706−40.0% | Reduced |
| Goldman Sachs Group Inc | 265,224 | $3.32M | 0.00% | +195,743+281.7% | Added |
| FMR LLC | 275,930 | $3.46M | 0.00% | −537,843−66.1% | Reduced |
| Sio Capital Management, LLC | 293,440 | $3.67M | 1.00% | −35,929−10.9% | Reduced |
| Charles Schwab Investment Management Inc | 317,761 | $3.98M | 0.00% | +18,881+6.3% | Added |
| Cormorant Asset Management, LP | 346,524 | $4.34M | 0.17% | 00.0% | Unchanged |
| Moloney Securities Asset Management, LLC | 362,125 | $4.53M | 0.83% | −51,300−12.4% | Reduced |
| Principal Financial Group Inc | 461,014 | $5.77M | 0.00% | +42,114+10.1% | Added |
| Millennium Management LLC | 513,282 | $6.43M | 0.01% | −883−0.2% | Reduced |
| JPMorgan Chase & Co | 515,761 | $6.46M | 0.00% | +313,096+154.5% | Added |
| Northern Trust Corp | 525,808 | $6.58M | 0.00% | +30,617+6.2% | Added |
| Price T Rowe Associates Inc | 596,992 | $7.47M | 0.00% | −31,683−5.0% | Reduced |
| Candriam Luxembourg S.C.A. | 633,162 | $7.93M | 0.05% | +633,162 | New |
| CHI Advisors LLC | 651,729 | $8.16M | 1.90% | −39,900−5.8% | Reduced |
| Morgan Stanley | 755,998 | $9.47M | 0.00% | +217,651+40.4% | Added |
| Geode Capital Management, LLC | 781,205 | $9.78M | 0.00% | +60,205+8.4% | Added |
| ArrowMark Colorado Holdings LLC | 2,365,643 | $27.6M | 0.21% | −27,436−1.1% | Reduced |
| State Street Corp | 2,786,461 | $34.9M | 0.00% | −2,362,298−45.9% | Reduced |
| Vanguard Group Inc | 2,792,057 | $35.0M | 0.00% | +479,041+20.7% | Added |
| BlackRock Inc. | 3,909,573 | $48.9M | 0.00% | −296,519−7.0% | Reduced |
| Capital World Investors | 4,269,000 | $53.4M | 0.01% | +207,000+5.1% | Added |
| Ghost Tree Capital, LLC | 0 | $0 | 0.00% | −200,000−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −164,964−100.0% | Sold out |
| Pura Vida Investments, LLC | 0 | $0 | 0.00% | −101,104−100.0% | Sold out |
| California Public Employees Retirement System | 0 | $0 | 0.00% | −94,500−100.0% | Sold out |
| Migdal Insurance & Financial Holdings Ltd. | 0 | $0 | 0.00% | −66,289−100.0% | Sold out |
| Thomasville National Bank | 0 | $0 | 0.00% | −54,858−100.0% | Sold out |
| 1623 Capital LLC | 0 | $0 | 0.00% | −12,276−100.0% | Sold out |
| Traynor Capital Management, Inc. | 0 | $0 | 0.00% | −11,000−100.0% | Sold out |
| SG Americas Securities, LLC | 0 | $0 | 0.00% | −9,923−100.0% | Sold out |
| Spire Wealth Management | 0 | $0 | 0.00% | −7,468−100.0% | Sold out |
| Pacer Advisors, Inc. | 0 | $0 | 0.00% | −6,622−100.0% | Sold out |
| Bank of Montreal | 0 | $0 | 0.00% | −2,084−100.0% | Sold out |
| Steward Partners Investment Advisory, LLC | 0 | $0 | 0.00% | −700−100.0% | Sold out |
| Manchester Financial Inc | 0 | $0 | 0.00% | −550−100.0% | Sold out |
| Point72 Hong Kong Ltd | 0 | $0 | 0.00% | −606−100.0% | Sold out |
| Sargent Bickham Lagudis LLC | 0 | $0 | 0.00% | −200−100.0% | Sold out |
| Tortoise Investment Management, LLC | 0 | $0 | 0.00% | −111−100.0% | Sold out |
| E Fund Management Co., Ltd. | – | – | – | – | Not filed |